Literature DB >> 32918127

A systematic scoping review on natural killer cell function in colorectal cancer.

Fiona S W Reid1,2, Natasha Egoroff3,4, Peter G Pockney3,5, Stephen R Smith3,5.   

Abstract

PURPOSE: Natural Killer (NK) cells are a vital part of immune surveillance and have been implicated in colorectal cancer development and prognosis. This systematic review aims to distil the literature on NK cells as it relates to colorectal cancer.
METHODS: All published studies over 10 years relating to NK cells and colorectal cancer were reviewed. All studies publishing in English, searchable via pubmed or through reference review and reporting directly on the nature or function of NK cells in colorectal cancer patients were included. Outcomes were determined as alterations or new information regarding NK cells in colorectal cancer patients.
RESULTS: Natural killer cells may be implicated in the development of colorectal cancer and may play a role in prognostication of the disease. NK cells are altered by the treatment (both surgical and medical) of colorectal cancer and it seems likely that they will also be a target for manipulation to improve colorectal cancer survival.
CONCLUSIONS: NK cell morphology and function are significantly affected by the development of colorectal cancer. Observation of NK cell changes may lead to earlier detection and better prognostication in colorectal cancer. Further study is needed into immunological manipulation of NK cells which may lead to improved colorectal cancer survival.

Entities:  

Keywords:  Colorectal neoplasms; Immunologic surveillance; Killer cells; MESH; Natural

Mesh:

Year:  2020        PMID: 32918127     DOI: 10.1007/s00262-020-02721-6

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  1 in total

1.  The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer.

Authors:  M Gharagozloo; H Kalantari; A Rezaei; M R Maracy; M Salehi; A Bahador; N Hassannejad; M Narimani; M H Sanei; B Bayat; H Ghazanfari
Journal:  Bratisl Lek Listy       Date:  2015       Impact factor: 1.278

  1 in total
  4 in total

1.  Deleted in lymphocytic leukemia 2 induces retinoic acid receptor beta promoter methylation and mitogen activated kinase-like protein activation to enhance viability and mobility of colorectal cancer cells.

Authors:  Liang Fu; Zhitao Shi; Bingxue Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer.

Authors:  Yaping Chen; Xiao Zheng; Changping Wu
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

3.  circ_0052184 Promotes Colorectal Cancer Progression via Targeting miR-604/HOXA9 Axis.

Authors:  Yandong Huang; Qinyang Bai; Zhanlong Wang; Hongbo Yu; Yanru Li; Hao Lu; Huimin Kang; Xuewei Shi; Kai Feng
Journal:  Anal Cell Pathol (Amst)       Date:  2022-08-27       Impact factor: 4.133

4.  Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway.

Authors:  Guoxiang Tong; Tianhao Peng; Ya Chen; Lijuan Sha; Huikang Dai; Yidong Xiang; Zhiqi Zou; Heli He; Sha Wang
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.